Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice

Human Molecular Genetics

Volumn 26, Issue 4, 2017, Pages 801-819

  Deguise, Marc Olivier ^a,b   De Repentigny, Yves ^a,b   McFall, Emily ^a,b   Auclair, Nicole ^a,b   Sad, Subash ^b   Kothary, Rashmi ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN 2; SMN1 PROTEIN, MOUSE; SURVIVAL MOTOR NEURON PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; FEMALE; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PATHOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY; THYMOCYTE; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; THYMUS;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; MUSCULAR ATROPHY, SPINAL; SURVIVAL OF MOTOR NEURON 1 PROTEIN; THYMOCYTES; THYMUS GLAND;

EID: 85018446285     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw434     Document Type: Article

References (76)

1. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P. and Zeviani, M. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
2. Liu, Q., Fischer, U., Wang, F. and Dreyfuss, G. (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell, 90, 1013-1021.
3. Pellizzoni, L., Kataoka, N., Charroux, B. and Dreyfuss, G. (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell, 95, 615-624.
4. Boyer, J.G., Bowerman, M. and Kothary, R. (2010) The many faces of SMN: deciphering the function critical to spinal muscular atrophy pathogenesis. Future Neurol., 5, 873-890.
5. Hamilton, G. and Gillingwater, T.H. (2013) Spinal muscular atrophy: going beyond the motor neuron. Trends Mol. Med., 19, 40-50.
6. Shababi, M., Lorson, C.L. and Rudnik-Schöneborn, S.S. (2014) Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?. J. Anat., 224, 15-28.
7. Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C.F. and Krainer, A.R. (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature, 478, 123-126.
8. Hua, Y., Liu, Y.H., Sahashi, K., Rigo, F., Bennett, C.F. and Krainer, A.R. (2015) Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models. Genes Dev., 29, 288-297.
9. McGivern, J.V., Patitucci, T.N., Nord, J.A., Barabas, M.E.A.E., Stucky, C.L. and Ebert, A.D. (2013) Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia, 61, 1418-1428.
10. Rindt, H., Feng, Z., Mazzasette, C., Glascock, J.J., Valdivia, D., Pyles, N., Crawford, T.O., Swoboda, K.J., Patitucci, T.N., Ebert, A.D., et al. (2015) Astrocytes influence the severity of spinal muscular atrophy. Hum. Mol. Genet., 24, 4094-4102.
11. Shafey, D., Cǒté, P.D. and Kothary, R. (2005) Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp. Cell Res., 311, 49-61.
12. Hayhurst, M., Wagner, A.K., Cerletti, M., Wagers, A.J. and Rubin, L.L. (2012) A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein. Dev. Biol., 368, 323-334.
13. Boyer, J.G., Deguise, M.O.O., Murray, L.M., Yazdani, A., De Repentigny, Y., Boudreau-Larivière, C. and Kothary, R. (2014) Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. Hum. Mol. Genet., 23, 4249-4259.
14. Boyer, J.G., Murray, L.M., Scott, K., De Repentigny, Y., Renaud, J.M.M. and Kothary, R. (2013) Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy. Skeletal Muscle, 3, 24.
15. Deguise, M.O.O., Boyer, J.G., McFall, E.R., Yazdani, A., De Repentigny, Y. and Kothary, R. (2016) Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy. Sci. Rep., 6, 28846.
16. Bricceno, K.V., Martinez, T., Leikina, E., Duguez, S., Partridge, T.A., Chernomordik, L.V., Fischbeck, K.H., Sumner, C.J. and Burnett, B.G. (2014) Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Hum. Mol. Genet., 23, 4745-4757.
17. Heier, C.R., Satta, R., Lutz, C. and DiDonato, C.J. (2010) Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum. Mol. Genet., 19, 3906-3918.
18. Bevan, A.K., Hutchinson, K.R., Foust, K.D., Braun, L., McGovern, V.L., Schmelzer, L., Ward, J.G., Petruska, J.C., Lucchesi, P.A., Burghes, A.H., et al. (2010) Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum. Mol. Genet., 19, 3895-3905.
19. Shababi, M., Habibi, J., Ma, L., Glascock, J.J., Sowers, J.R. and Lorson, C.L. (2012) Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J. Mol. Cell. Cardiol., 52, 1074-1082.
20. Shababi, M., Habibi, J., Yang, H.T., Vale, S.M., Sewell, W.A. and Lorson, C.L. (2010) Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum. Mol. Genet., 19, 4059-4071.
21. Bowerman, M., Michalski, J.P.P., Beauvais, A., Murray, L.M., DeRepentigny, Y. and Kothary, R. (2014) Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology. Hum. Mol. Genet., 23, 3432-3444.
22. Bowerman, M., Swoboda, K.J., Michalski, J.P.P., Wang, G.S.S., Reeks, C., Beauvais, A., Murphy, K., Woulfe, J., Screaton, R.A., Scott, F.W., et al. (2012) Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol., 72, 256-268.
23. Wang, C.H., Finkel, R.S., Bertini, E.S. and Schroth, M. (2007) Consensus statement for standard of care in spinal muscular atrophy. J. Child Neurol., 22, 1027-1049.
24. Gombash, S.E., Cowley, C.J., Fitzgerald, J.A., Iyer, C.C., Fried, D., McGovern, V.L., Williams, K.C., Burghes, A.H., Christofi, F.L., Gulbransen, B.D., et al. (2015) SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum. Mol. Genet., 24, 3847-3860.
25. Sintusek, P., Catapano, F., Angkathunkayul, N., Marrosu, E., Parson, S.H., Morgan, J.E., Muntoni, F. and Zhou, H. (2016) Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment. PloS One, 11
26. Bürglen, L., Spiegel, R., Ignatius, J., Cobben, J.M., Landrieu, P., Lefebvre, S., Munnich, A. and Melki, J. (1995) SMN gene deletion in variant of infantile spinal muscular atrophy. The Lancet, 346
27. Menke, L.A., Poll-The, B.T. and Clur, S.A. (2008) Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am. J. Med. Genet. A, 146A, 740-744.
28. Tein, I., Sloane, A.E., Donner, E.J., Lehotay, D.C., Millington, D.S. and Kelley, R.I. (1995) Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?. Pediatr. Neurol., 12, 21-30.
29. Crawford, T.O., Sladky, J.T. and Hurko, O. (1999) Abnormal fatty acid metabolism in childhood spinal muscular atrophy. Ann. Neurol., 45, 337-343.
30. Delves, P.J. and Roitt, I.M. (2000) The immune system. First of two parts. N. Engl. J. Med., 343, 37-49.
31. Delves, P.J. and Roitt, I.M. (2000) The immune system. Second of two parts. N. Engl. J. Med., 343, 108-117.
32. Mebius, R.E. and Kraal, G. (2005) Structure and function of the spleen. Nat. Rev. Immunol., 5, 606-616.
33. Tarantino, G., Scalera, A. and Finelli, C. (2013) Liver-spleen axis: intersection between immunity, infections and metabolism. World J. Gastroenterol., 19, 3534-3542.
34. Dachs, E., Hereu, M., Piedrafita, L., Casanovas, A., Calderó, J. and Esquerda, J.E. (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J. Neuropathol. Exp. Neurol., 70, 444-461.
35. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossoll, W., Rossol, W., et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
36. Eshraghi, M., McFall, E., Gibeault, S. and Kothary, R. (2016) Effect of genetic background on the phenotype of the Smn2B/-mouse model of spinal muscular atrophy. Hum. Mol. Genet., Epub ahead of print.
37. Cesta, M.F. (2006) Normal structure, function, and histology of the spleen. Toxicol. Pathol., 34, 455-465.
38. Vacchio, M.S., Ciucci, T. and Bosselut, R. (2016) 200 Million Thymocytes and I: A Beginner's Survival Guide to T Cell Development. Methods Mol Biol., 1323, 3-21.
39. Elmore, S.A. (2006) Enhanced histopathology of the thymus. Toxicol. Pathol., 34, 656-665.
40. Starr, T.K., Jameson, S.C. and Hogquist, K.A. (2003) Positive and negative selection of T cells. Ann. Rev. Immunol., 21, 139-176.
41. Hogquist, K.A., Baldwin, T.A. and Jameson, S.C. (2005) Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol., 5, 772-782.
42. Lee, J.Y. and Love, P.E. (2016) Assessment of T Cell Development by Flow Cytometry. Methods Mol Biol., 1323, 47-64.
43. Hu, Q., Nicol, S.A., Suen, A.Y. and Baldwin, T.A. (2012) Examination of thymic positive and negative selection by flow cytometry. J. Vis. Exp., 68, 4269.
44. Burlet, P., Huber, C., Bertrandy, S., Ludosky, M.A., Zwaenepoel, I., Clermont, O., Roume, J., Delezoide, A.L., Cartaud, J., Munnich, A., et al. (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum. Mol. Genet., 7, 1927-1933.
45. Ransohoff, R.M. (2016) How neuroinflammation contributes to neurodegeneration. Science, 353, 777-783.
46. Banerjee, R., Mosley, R.L., Reynolds, A.D., Dhar, A., Jackson-Lewis, V., Gordon, P.H., Przedborski, S. and Gendelman, H.E. (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PloS One, 3
47. O'Rourke, J.G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A.J., Muhammad, A.K., Ho, R., Carmona, S., Vit, J.P., Zarrow, J., et al. (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science, 351, 1324-1329.
48. Beers, D.R., Henkel, J.S., Zhao, W., Wang, J. and Appel, S.H. (2008) CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci., 105, 15558-15563.
49. Chiu, I.M., Chen, A., Zheng, Y., Kosaras, B., Tsiftsoglou, S.A., Vartanian, T.K., Brown, R.H., Jr. and Carroll, M.C. (2008) T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci., 105, 17913-17918.
50. Hirahara, H., Ogawa, M., Kimura, M., Iiai, T., Tsuchida, M., Hanawa, H., Watanabe, H. and Abo, T. (1994) Glucocorticoid independence of acute thymic involution induced by lymphotoxin and estrogen. Cell. Immunol., 153, 401-411.
51. Screpanti, I., Morrone, S., Meco, D., Santoni, A., Gulino, A., Paolini, R., Crisanti, A., Mathieson, B.J. and Frati, L. (1989) Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J. Immunol., 142, 3378-3383.
52. Savino, W. and Dardenne, M. (2000) Neuroendocrine control of thymus physiology. Endocr. Rev., 21, 412-443.
53. Hachiya, Y., Arai, H., Hayashi, M., Kumada, S., Furushima, W., Ohtsuka, E., Ito, Y., Uchiyama, A. and Kurata, K. (2005) Autonomic dysfunction in cases of spinal muscular atrophy type 1 with long survival. Brain Dev., 27, 574-578.
54. Araujo, A., Araujo, M. and Swoboda, K.J. (2009) Vascular perfusion abnormalities in infants with spinal muscular atrophy. J. Pediatr., 155, 292-294.
55. Rudnik,-Schöneborn, S. and Vogelgesang, S. (2010) Digital necroses and vascular thrombosis in severe spinal muscular atrophy. Muscle Nerve, 42, 144-147.
56. Ackerman, K.D., Felten, S.Y., Dijkstra, C.D., Livnat, S. and Felten, D.L. (1989) Parallel development of noradrenergic innervation and cellular compartmentation in the rat spleen. Exp. Neurol., 103, 239-255.
57. Bellinger, D.L., Lorton, D., Felten, S.Y. and Felten, D.L. (1992) Innervation of lymphoid organs and implications in development, aging, and autoimmunity. Int. J. Immunopharmacol., 14, 329-344.
58. Baggiolini, M. (1998) Chemokines and leukocyte traffic. Nature, 392, 565-568.
59. Rennert, P.D., Browning, J.L. and Mebius, R. (1996) Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med., 184, 1999-2006.
60. Matsumoto, M., Fu, Y.X., Molina, H. and Chaplin, D.D. (1997) Lymphotoxin-alpha-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev., 156, 137-144.
61. Fütterer, A., Mink, K., Luz, A., Kosco-Vilbois, M.H. and Pfeffer, K. (1998) The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity, 9, 59-70.
62. Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E. and Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell, 99, 23-33.
63. Ettinger, R., Browning, J.L., Michie, S.A., van Ewijk, W. and McDevitt, H.O. (1996) Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci., 93, 13102-13107.
64. Ngo, V.N., Korner, H., Gunn, M.D., Schmidt, K.N., Riminton, D.S., Cooper, M.D., Browning, J.L., Sedgwick, J.D. and Cyster, J.G. (1999) Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med., 189, 403-412.
65. Gunn, M.D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L.T. and Nakano, H. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med., 189, 451-460.
66. Geijtenbeek, T.B., Groot, P.C., Nolte, M.A., van Vliet, S.J., Gangaram-Panday, S.T., van Duijnhoven, G.C., Kraal, G., van Oosterhout, A.J. and van Kooyk, Y. (2002) Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood, 100, 2908-2916.
67. Koppel, E.A., Ludwig, I.S., Hernandez, M.S., Lowary, T.L., Gadikota, R.R., Tuzikov, A.B., Vandenbroucke-Grauls, C.M., van Kooyk, Y., Appelmelk, B.J. and Geijtenbeek, T.B. (2004) Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiology, 209, 117-127.
68. Elomaa, O., Kangas, M., Sahlberg, C., Tuukkanen, J., Sormunen, R., Liakka, A., Thesleff, I., Kraal, G. and Tryggvason, K. (1995) Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell, 80, 603-609.
69. Jones, C., Virji, M. and Crocker, P.R. (2003) Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol., 49, 1213-1225.
70. Narver, H.L., Kong, L., Burnett, B.G., Choe, D.W., Bosch-Marcé, M., Taye, A.A., Eckhaus, M.A. and Sumner, C.J. (2008) Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann. Neurol., 64, 465-470.
71. Tsai, L.K.K., Tsai, M.S.S., Lin, T.B.B., Hwu, W.L.L. and Li, H. (2006) Establishing a standardized therapeutic testing protocol for spinal muscular atrophy. Neurobiol. Dis., 24, 286-295.
72. Hsieh-Li, H., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C. and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet., 24, 66-70.
73. Somers, E., Lees, R.D., Hoban, K., Sleigh, J.N., Zhou, H., Muntoni, F., Talbot, K., Gillingwater, T.H. and Parson, S.H. (2016) Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy. Ann. Neurol., 79, 217-230.
74. Somers, E., Stencel, Z., Wishart, T.M., Gillingwater, T.H. and Parson, S.H. (2012) Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul. Disord., 22, 435-442.
75. Turner, M.D., Nedjai, B., Hurst, T. and Pennington, D.J. (2014) Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta, 1843, 2563-2582.
76. Shafey, D., Boyer, J.G., Bhanot, K. and Kothary, R. (2010) Identification of novel interacting protein partners of SMN using tandem affinity purification. J. Proteome Res., 9, 1659-1669.